Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.
Alessio G MorgantiFrancesco CelliniMilly BuwengeAlessandra ArcelliSergio AlfieriFelipe A CalvoRiccardo CasadeiSavino CillaFrancesco DeodatoGiancarmine Di GioiaMariacristina Di MarcoLorenzo FuccioFederica BertiniAlessandra GuidoJoseph M HermanGabriella MacchiaBert W MaidmentRobert C MillerFrancesco MinniPaolo PassoniChiara ValentiniAlessia ReWilliam F RegineMichele ReniMassimo FalconiVincenzo ValentiniGian Carlo MattiucciPublished in: BMC cancer (2019)
Increasing doses of CRT seems to favorably impact on OS in adjuvant setting. The conflicting results of randomized trials on adjuvant CRT in PDAC could be due to < 45 Gy dose generally used.